Z-1330-2013 Class III Terminated
FDA device recall Z-1330-2013 was initiated by Bio-Rad Laboratories, Inc. on Apr 15, 2013 and is designated Class III. Reason for recall: The Liquichek" ToRCH Plus IgM Control - Positive, contains detectable levels of HCV RNA which originated from the non-specific human IgM component used in the mouse monoclonal antibody conjugation… The recall status is terminated (terminated Aug 1, 2013). Affected quantity: 211 boxes and 5 MiniPaks.
Recall details
- Product Type
- Devices
- Report Date
- May 22, 2013
- Initiation Date
- Apr 15, 2013
- Termination Date
- Aug 1, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 211 boxes and 5 MiniPaks
Product description
Liquichek" ToRCH Plus IgM Control - Positive Liquichek ToRCH Plus IgM Control is intended for use as an unassayed quality control serum to monitor precision of IgM laboratory testing procedures for the analytes listed in this package insert. This product is not intended for use in blood donor screening assays. Analytes claimed with this lot of Liquichek ToRCH Plus IgM Control: ¿ Cytomegalovirus (CMV) IgM ¿ Herpes Simplex Virus Type 1/2 (HSV-1/2) IgM ¿ Rubella Virus IgM ¿ Toxoplasma gondii IgM
Reason for recall
The Liquichek" ToRCH Plus IgM Control - Positive, contains detectable levels of HCV RNA which originated from the non-specific human IgM component used in the mouse monoclonal antibody conjugation process for this product.
Distribution pattern
Worldwide Distribution - Distributed in San Juan Puerto Rico and the states of NM, NY, MN, OR and WI., and the countries of Australia, Brazil, France, Italy, Korea, and New Zealand.
Code information
Lot Number 18972, Catalog Number 229 and 229PX.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1330-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026